drugset / Trial / NCT01815515
Evaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
This research is being done to see if an investigational radioactive drug called 18F-DCFBC can help us find cancer that has spread (metastatic disease) from its original site in people who have cancer in their prostate to other parts of their body.
Timeline
- Start
- 2013-03
- Primary completion
- 2015-07
- Completion
- 2015-11-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-DCFBC | Diagnostic / imaging agent | 10 mbq | Intravenous |